SCHEMBL19794441

SCHEMBL19794441

c1ccc(-c2ccc(-c3ccccc3-c3cc(-c4ccccc4-c4ccc(-c5ccccc5)nc4)cc(-c4ccccc4-c4ccc(-c5ccccn5)nc4)c3)cn2)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGDS O60760 2/20 0.52
CYP2A6 P11509 1/20 0.46
LMNA P02545 3/20 0.45
KDM4E B2RXH2 3/20 0.45
P4HTM Q9NXG6 2/20 0.45
CYP1A2 P05177 1/20 0.45
POLB P06746 1/20 0.45
CCR1 P32246 1/20 0.45
CCR5 P51681 1/20 0.45
CCR8 P51685 1/20 0.45
METAP1 P53582 1/20 0.45
BLM P54132 1/20 0.45
HIF1A Q16665 1/20 0.45
DOHH Q9BU89 1/20 0.45
KDR P35968 1/20 0.44
NPC1 O15118 3/20 0.44
RAB9A P51151 2/20 0.44
L3MBTL1 Q9Y468 2/20 0.44
ALDH1A1 P00352 1/20 0.44
TP53 P04637 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18015360 0.97 HPGDS (0.49) HPGDSCYP2A6LMNAKDM4EP4HTM
SCHEMBL21125929 0.95 CHEK2 (0.49) HPGDSCYP2A6LMNAP4HTMKDR
SCHEMBL20068613 0.95 CHEK2 (0.48) HPGDSCYP2A6LMNAKDM4EP4HTM
SCHEMBL21125828 0.93 CHEK2 (0.49) HPGDSCYP2A6LMNAKDM4EP4HTM
SCHEMBL12925598 0.93 KDM4E (0.52) HPGDSCYP2A6LMNAKDM4EP4HTM
SCHEMBL21397867 0.93 HPGDS (0.47) HPGDSCYP2A6LMNAKDM4EP4HTM
SCHEMBL21125087 0.92 HSD17B1 (0.49) HPGDSCYP2A6LMNAKDM4EP4HTM
SCHEMBL21721920 0.92 LDHA (0.50) HPGDSLDHADHODHHSD17B1HSD17B2
SCHEMBL28785613 0.90 HPGDS (0.58) HPGDSCYP2A6LMNAKDM4EP4HTM
SCHEMBL18015574 0.90 LDHA (0.52) HPGDSLDHAHSD17B1HSD17B2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11024815-B2 Metal complexes MERCK PATENT GMBH (DE) 2021-06-01 US disclosed
EP-3254317-B1 METAL COMPLEXES MERCK PATENT GMBH (DE) 2019-07-31 EP disclosed
US-20180026209-A1 Metal Complexes MERCK PATENT GMBH (DE) 2018-01-25 US disclosed
US-20180026209-A1 Metal Complexes MERCK PATENT GMBH (DE) 2018-01-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11024815-B2 Metal complexes EXOC4, EXOC3, TIMCC HPGDS 4832/4885CYP2A6 3821/4885LMNA 4536/4885
US-20180026209-A1 Metal Complexes AP3M1, AP2M1, SOD1 HPGDS 4844/4885CYP2A6 4002/4885LMNA 4570/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.